Skip to main content
. 2007 Jan 18;93(7):808–813. doi: 10.1136/hrt.2006.095208

graphic file with name ht95208.f1.jpg

Figure 1 Percentage changes (mean (SE)) in regional myocardial blood flow (MBF) at rest and during dipyridamole (Dip) infusion as well as in regional coronary flow reserve (CFR) from enrolment to 6 months treatment are presented for patients treated with placebo (group 1) or with carvedilol (group 2). The two groups significantly differed in analysis of variance.